Quest 10 Wealth Builders, Inc. Roivant Sciences Ltd. Transaction History
Quest 10 Wealth Builders, Inc.
- $108 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
365Shares Held
458MCall Options Held
8.66MPut Options Held
761K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.25 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$934 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$811 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$739 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$716 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.7B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...